Literature DB >> 17318898

Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep.

Véronique Viateau1, Geneviève Guillemin, Valérie Bousson, Karim Oudina, Didier Hannouche, Laurent Sedel, Delphine Logeart-Avramoglou, Hervé Petite.   

Abstract

Standardized particulate bone constructs, obtained by expanding autologous mesenchymal stem cells (MSCs) onto coral granules in vitro, were transplanted into long-bone, critical-size defects in sheep. Control experiments were also performed in which autologous bone grafts were implanted. Defect cavities were lined with a preformed vascularized membrane (induced by temporarily inserting a cement spacer for 6 weeks prior to bone construct implantation), which served as a mold keeping the engineered bone granules in place. Radiographic, histological, and computed tomographic tests performed 6 months later showed that the osteogenic abilities of the engineered construct and autograft were significantly greater than those of coral scaffold alone. No significant differences were found between the amount of newly formed bone in defects filled with coral/MSCs and those filled with autograft, yet radiological scores differed significantly between the two groups (21% and 100% healed cortices, respectively). The present study on a clinically relevant animal model provides the first evidence that standardized particulate bone constructs can be used to repair large bone defects and that their osteogenic ability approaches that of bone autograft, the bone repair benchmark. By proving feasibility, the present study makes possible the treatment of segmental bone losses with bone constructs engineered from granules, a process which is much simpler than preparing customized massive constructs using computer-assisted techniques. Important parameters, such as the rate of scaffold resorption and the number of MSCs to be seeded on the scaffolds, need to be optimized before reaching pertinent definitive conclusions. (c) 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318898     DOI: 10.1002/jor.20352

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  48 in total

Review 1.  The role of mesenchymal stem cells in bone repair and regeneration.

Authors:  Pavel Sponer; Tomáš Kučera; Daniel Diaz-Garcia; Stanislav Filip
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-10-08

Review 2.  Scaffold translation: barriers between concept and clinic.

Authors:  Scott J Hollister; William L Murphy
Journal:  Tissue Eng Part B Rev       Date:  2011-09-21       Impact factor: 6.389

Review 3.  Cell sources for bone tissue engineering: insights from basic science.

Authors:  Céline Colnot
Journal:  Tissue Eng Part B Rev       Date:  2011-09-27       Impact factor: 6.389

4.  The use of total human bone marrow fraction in a direct three-dimensional expansion approach for bone tissue engineering applications: focus on angiogenesis and osteogenesis.

Authors:  Julien Guerrero; Hugo Oliveira; Sylvain Catros; Robin Siadous; Sidi-Mohammed Derkaoui; Reine Bareille; Didier Letourneur; Joëlle Amédée
Journal:  Tissue Eng Part A       Date:  2014-12-01       Impact factor: 3.845

5.  Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrow.

Authors:  Anita Undale; Daniel Fraser; Theresa Hefferan; Ross A Kopher; James Herrick; Glenda L Evans; Xiaodong Li; Sanjeev Kakar; Meredith Hayes; Elizabeth Atkinson; Michael J Yaszemski; Dan S Kaufman; Jennifer J Westendorf; Sundeep Khosla
Journal:  J Orthop Res       Date:  2011-06-14       Impact factor: 3.494

6.  Comprehensive histological evaluation of bone implants.

Authors:  Claudia Rentsch; Wolfgang Schneiders; Suzanne Manthey; Barbe Rentsch; Stephan Rammelt
Journal:  Biomatter       Date:  2014-02-06

Review 7.  Induced membrane for treatment of critical sized bone defect: a review of experimental and clinical experiences.

Authors:  Jean-Charles Aurégan; Thierry Bégué
Journal:  Int Orthop       Date:  2014-07-02       Impact factor: 3.075

8.  Engineered cell-free scaffold with two-stage delivery of miRNA-26a for bone repair.

Authors:  Joseph Paquet; Adrien Moya; Morad Bensidhoum; Hervé Petite
Journal:  Ann Transl Med       Date:  2016-05

Review 9.  Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance.

Authors:  Mirjam Fröhlich; Warren L Grayson; Leo Q Wan; Darja Marolt; Matej Drobnic; Gordana Vunjak-Novakovic
Journal:  Curr Stem Cell Res Ther       Date:  2008-12       Impact factor: 3.828

10.  Reduced serum and hypoxic culture conditions enhance the osteogenic potential of human mesenchymal stem cells.

Authors:  Bernard Y K Binder; John E Sagun; J Kent Leach
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.